✦ LIBER ✦

Rebalancing Immune Specificity and Function in Cancer by T-Cell Receptor Gene Therapy

✍ Scribed by Akshata Udyavar; Terrence L. Geiger

Publisher: Springer
Year: 2010
Tongue: English
Weight: 246 KB
Volume: 58
Category: Article
ISSN: 0004-069X
DOI: 10.1007/s00005-010-0090-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T cell clones which share T cell recepto

T cell clones which share T cell receptor epitopes differ in phenotype, function and specificity

✍ Hans Yssel; Dominique Blanchard; Art Boylston; Jan E. De Vries; Hergen Spits 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 786 KB

Gene-modified T cells for adoptive immun

Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo

✍ Cor H. J. Lamers; Sabine C. L. Langeveld; Corrien M. Groot-van Ruijven; Reno Deb 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 380 KB

Tumor antigen-specific T helper cells in

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

✍ K. L. Knutson; M. L. Disis 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 300 KB

T cell receptor β chain gene rearrangeme

T cell receptor β chain gene rearrangements and Vβ gene usage in horse cytochrome c-specific T cell hybridomas

✍ Susanne Baumhüter; Nicolas Fasel; Giampietro Corradin; John Guardiola 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

## T cell receptor p chain gene rearrangements and V, gene usage in horse cytochrome c-specific T cell hybridomas* Comparison of T cell receptor a and $-chain genes in murine major histocompatibility complex (MHC) class I and class 11-restricted T cell clones and hybridomas recognizing different a

Myelin basic protein peptide specificity

Myelin basic protein peptide specificity and T-cell receptor gene usage of HPRT mutant T-cell clones in patients with multiple sclerosis

✍ Dr Patricia A. Lodge; Mark Allegretta; Lawrence Steinman; Subramaniam Sriram 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

Cancer gene therapy with HSV-tk/GCV syst

Cancer gene therapy with HSV-tk/GCV system depends on t-cell-mediated immune responses and causes apoptotic death of tumor cells In vivo

✍ Shigeki Kuriyama; Masaji Kikukawa; Kazuhiro Masui; Hirotsugu Okuda; Toshiya Naka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 620 KB

To examine the immunological mechanisms involved in cancer gene therapy using the herpes simplex virus thymidine kinase (HSV-tk) gene and ganciclovir (GCV), murine hepatocellular carcinoma (HCC) cells, BNL1ME A.7R.1, were transduced retrovirally with the HSV-tk gene. HSV-tk-transduced cells exhibite